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Early  antigen-tracing  experiments  established 
that cells within the center of follicles captured 
and retained opsonized antigens for long peri-
ods. Ultrastructural studies led to the descrip-
tion of a highly dendritic-shaped cell that was 
responsible for antigen capture and display, and 
these  cells  became  known  as  follicular  DCs 
(FDCs; Szakal et al., 1989; Tew et al., 1993). 
FDCs within primary follicles express high 
amounts of complement receptors-1 and -2 
(CR1 or CD35 and CR2 or CD21) and can be 
induced to express FcRIIb (Roozendaal and 
Carroll, 2007; Allen and Cyster, 2008). FDCs 
are also prominent in the light zone of germinal 
centers  (GCs),  where  they  express  FDC-M1 
(MFG-E8) and VCAM-1, and are heavily dec-
orated with activated C4 (Allen and Cyster, 2008; 
Kranich et al., 2008). The stromal cells around 
the follicle perimeter express some markers in 
common with FDCs, such as BP3 (CD157),   
but  are  otherwise  distinct  from  FDCs  and   
from ER-TR7–expressing T zone stromal cells   
(Cyster et al., 2000). The stromal cells in the 
outer follicle have been classified as marginal 
reticular cells (Katakai et al., 2008).
FDCs develop within follicles after the ar-
rival of B cells (Balogh et al., 2001), and their 
induction  is  dependent  on  LT12  derived 
from B cells, as well as TNF from B cells and 
additional cell types (Fu and Chaplin, 1999; 
Allen and Cyster, 2008). Although their devel-
opmental pathway has not been fully elucidated, 
they are radiation resistant and are considered 
to be mesenchymal in origin (Tew et al., 1993; 
Cyster et al., 2000; Allen and Cyster, 2008). 
B cell recruitment to nascent follicles is depen-
dent on CXCL13, the chemokine ligand for 
CXCR5 (Cyster et al., 2000). CXCL13 is ex-
pressed  early  in  lymphoid  tissue  develop-
ment, and expression is augmented by LT12 
(Cupedo et al., 2004; Allen and Cyster, 2008). 
CXCL13 is made in a reticular pattern that 
overlaps  with  both  the  non-FDC  and  FDC 
stromal networks (Cyster et al., 2000). How-
ever, the relative contribution of non-FDC 
stromal cells and FDCs to CXCL13 produc-
tion has not been defined.
The antigen presentation role of FDCs has 
been supported by in vivo and in vitro studies 
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Follicular dendritic cells (FDCs) retain and display opsonized antigens in primary follicles 
and germinal centers (GCs). However, their roles beyond antigen presentation have been 
incompletely defined. In this study, we tested the impact of selective FDC ablation on 
short-term follicle and GC function. Within 2 d of FDC ablation, primary follicles lost their 
homogeneity and became disorganized bands of cells around T zones. These B cell areas 
retained CXCL13-expressing stromal cells but often exhibited inappropriate ER-TR7 and 
CCL21 expression. Ablation of GC FDCs led to the disappearance of GCs. When B cell death 
was prevented using a Bcl2 transgene, FDC ablation led to splenic GC B cell dispersal. 
Mesenteric lymph node GCs were more resistant but became dispersed when sphingosine-1-
phosphate receptor-2 was also removed. These experiments indicate that FDCs help main-
tain primary follicles as a B cell exclusive niche and define a critical role for FDCs in cell 
retention within GCs.
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B cells (Fig. 1 A and not depicted). However, the mice showed 
signs of paralysis and ill health and had elevated circulating 
corticosteroids within 1–2 d of treatment (Fig. 1 B), requiring 
their  euthanasia.  CD21-Cre  activity  has  been  detected  in 
brain and kidney (Schmidt-Supprian and Rajewsky, 2007), 
and we confirmed that DTR transcripts were expressed in 
these sites (not depicted). We considered the possibility that 
the toxic effects in CD21-DTR chimeric mice were caused 
by DTx access to DTR in the brain and speculated that toxin 
movement across the blood brain barrier might be slow com-
pared with access to FDCs in lymphoid tissues. We therefore 
tested the protective effect of following DTx treatment after 
3 h with injection of DTx-neutralizing polyclonal antibodies. 
Using this approach, it was possible to achieve ablation of 
FDCs in spleen and LNs (Fig. 1 A) while maintaining low 
circulating corticosteroid levels (Fig. 1 B) and normal health 
during the 2 d of analysis, although longer treatment periods 
were not possible as the health of the mice deteriorated after 
day 2. Repeated treatment with DTx-neutralizing antibodies 
did not allow us to extend the period of study. Treatment of 
control mice with the same DTx and antibody combination 
for 2–3 d had no effect on FDCs or mouse health (Fig. 1 A). 
The 2-d FDC ablation protocol did not alter total cell num-
bers or B cell frequencies in spleen or LNs (Fig. 1, C and D) 
or B cell activation status (Fig. 1 E), and there was no change 
in the rate of B cell, T cell, or CD11c+ cell turnover as as-
sessed by bromodeoxyuridine incorporation over the 2 d (not 
depicted). In all of the experiments described below, DTx 
treatment was followed at 2.5–3 h by anti-DTx treatment.
FDCs help establish primary follicle identity
Although FDCs are well defined as a major stromal cell type 
within the central region of the primary follicle, their rela-
tionship to the broad follicular stromal network identified by 
BP3 (McNagny et al., 1991) and CXCL13 (Cyster et al., 
2000) has been unclear. In the spleen, FDC ablation left the 
BP3+ follicular stromal cell network largely intact (Fig. 2 A). 
In contrast, in pLNs, FDC ablation led to a marked depletion 
of the BP3-expressing follicular stromal cell network (Fig. 2 A). 
mLNs were more difficult to study in this context because of 
the constitutive presence of GCs, but from a limited assess-
ment, there was a similar loss of primary follicle BP3 staining 
as in pLNs (not depicted). These observations reveal a previ-
ously unappreciated dichotomy in the stromal organization 
of spleen and LN follicles and suggest the presence of a greater 
density of BP3+ non-FDC stromal cells in splenic compared 
with LN follicles. In situ hybridization was used to identify 
the stromal cells expressing CXCL13. FDC ablation led to a 
contraction of the area occupied by CXCL13+ cells in the 
spleen, with the strongest remaining signal being at the outer 
follicle (Fig. 2 B), and there was a corresponding approxi-
mately twofold reduction in the CXCL13 transcript abun-
dance in total spleen tissue (Fig. 2 C). In agreement with the 
overlap in distribution of CXCL13+ and CD35+ cell distri-
bution, combined CXCL13 in situ hybridization and staining 
for CD35 in control spleen provided evidence for the presence 
(Victoratos et al., 2006; Roozendaal and Carroll, 2007;   
Suzuki et al., 2009; El Shikh et al., 2010). Additional func-
tions for the cells, such as serving as a source of BAFF (Hase 
et al., 2004; Suzuki et al., 2010) and promoting GC B cell 
mutation (El Shikh et al., 2010), have been suggested, but 
these roles have not been rigorously tested in vivo. Experi-
ments in lymphotoxin- and TNF-deficient mice have pro-
vided important correlations regarding a requirement for 
FDCs in the organization of primary follicles and in mount-
ing GC responses (Fu and Chaplin, 1999; Allen and Cyster, 
2008). However, inferences about the roles of FDCs made 
through these studies are confounded by the fact that these 
cytokines are needed for multiple functions, including chemo-
kine and integrin ligand expression by the entire lymphoid 
stroma (Ngo et al., 1999; Lu and Cyster, 2002; Browning, 
2008) and for the maintenance of various lymphoid tissue 
macrophages and DCs (Kabashima et al., 2005; Wang et al., 
2005; Browning, 2008; Phan et al., 2009). Selective genetic 
restoration of TNFR1 within FDCs in mice that otherwise 
lacked this receptor provided more direct evidence that FDCs 
are required for follicle development and efficient GC forma-
tion (Victoratos et al., 2006). In these animals, FDCs were 
restored from early development and thus their role in main-
taining the follicle or in supporting established GC responses 
was not assessed.
In this study, we have used a short-term conditional abla-
tion system to study the role of FDCs in primary follicles and 
GCs. We show that FDC ablation before immunization leads 
to a rapid disruption in follicular organization and a reduction 
in B cell motility. Ablation of FDCs during the GC response 
causes rapid GC B cell dispersal and death. These observations 
suggest that FDCs help establish primary follicle identity, and 
they act to retain and promote the survival of GC B cells.
RESULTS
FDC ablation in CD21-Cre × ROSADTR mice
CD21 expression in the immune system is restricted to FDCs 
and B cells (Roozendaal and Carroll, 2007), and in CD21-
Cre mice, Cre is highly active in these cells types (Victoratos 
et al., 2006). With the goal of generating mice that allowed 
selective diphtheria toxin (DTx)–mediated ablation of FDCs, 
CD21-Cre mice were intercrossed with mice harboring the 
DTx receptor (DTR) gene downstream of a floxed stop ele-
ment in the ubiquitously active ROSA26 locus (ROSADTR 
mice). Cells in these mice expressing CD21 also express DTR 
and are selectively vulnerable to deletion on exposure to DTx. 
The resulting CD21-Cre+ROSADTR+ mice were irradiated 
and reconstituted with wild-type BM. In these mice (termed 
CD21-DTR chimeric mice for simplicity), radiation-resistant 
FDCs were expected to remain sensitive to DTx, whereas   
B cells would be DTR-negative donor-derived cells and thus 
toxin resistant. Indeed, when such mice were treated with 
20–30 ng DTx (1 ng/g), amounts similar to or lower than 
those used in other DTR-based cell deletion experiments, 
there was ablation of FDCs in spleen, peripheral LNs (pLNs), 
and mesenteric LNs (mLNs) within 1 d without loss of naive JEM Vol. 208, No. 12 
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Although B cells express CD35, the more abundant ex-
pression in FDCs led us to quantitate CD35 transcript levels 
in whole tissue as a further method for assessing FDC abla-
tion. 2 d after DTx treatment of CD21-DTR chimeric mice, 
there was a significant reduction in CD35 (Cr1) transcripts in 
total LN samples (Fig. 2 C). The reduction in spleen was less 
significant,  likely  because  of  the  B  cell  preponderance  in 
spleen and the high expression of CD35 by marginal zone B cells 
(Martin and Kearney, 2002). MFG-E8, recognized by the 
FDC-M1  antibody,  is  made  by  radiation-resistant  stromal 
cells and is detected on the surface of FDCs, at low levels in 
primary follicles and more abundantly on GC FDCs (Allen 
and Cyster, 2008; Kranich et al., 2008). Total transcript analysis 
of costaining cells (Fig. 2 B). CXCL13 protein distribution in 
the spleen mirrored the messenger RNA (mRNA) distribu-
tion (Fig. 2 D). In pLNs, there was a similar contraction of 
CXCL13 mRNA and protein distribution after FDC abla-
tion (Fig. 2, B and D), although there was not a measurable 
change in total transcript abundance (Fig. 2 C). Given that 
costaining suggested significant colocalization of CXCL13 
message and CD35 protein, the lack of reduction in pLN 
CXCL13 transcripts was surprising but might be a conse-
quence of a compensatory up-regulation by stromal cells in 
the subcapsular region (Fig. 2 B). In mLNs, FDC ablation led 
to a similar reduction in CXCL13 mRNA abundance to that 
observed in the spleen (Fig. 2 C).
Figure 1.  FDC ablation in CD21-DTR chimeric mice after serial DTx and anti-DTx treatment. (A) ROSADTR+CD21Cre+ mice that express the DTR in 
CD21+ cells or ROSADTR+CD21Cre control mice were reconstituted with wild-type BM, and the chimeric mice were saline (control [Ctrl]) or DTx treated 
and analyzed after the indicated number of days. In some cases, the mice were also treated with goat polyclonal antibody to DTx 3 h after DTx treatment 
(+Ab). Spleen (Spl) and pLN sections were stained for IgD to detect follicular B cells (brown) and CD35 to detect FDCs (blue). Bar, 400 µm. (B) Serum corti-
costerone concentration in control-, DTx-, or DTx- and anti-DTx antibody–treated CD21-DTR chimeric mice at day 2. Data are pooled from at least eight 
mice per group analyzed in two experiments (mean ± SEM). (C–E) Total cell number (C), B220+ B cell frequency (D), and flow cytometric analysis (E) of  
B cell CD69 and CD86 expression in pLNs, spleen, and mLNs at day 2 after control or DTx plus anti-DTx antibody treatment. In the bar graphs, each point 
indicates an individual animal, and bars indicate the mean. Data in E are representative of three mice. Statistical analysis in B–D was performed with a 
two-tailed unpaired Student’s t test. ***, P < 0.001; n.s., not significant.2500 FDCs maintain follicles and retain B cells in GCs | Wang et al.
Figure 2.  DTx-mediated selective FDC ablation disrupts B cell follicle architecture despite retention of CXCL13. Unimmunized CD21-DTR chi-
meras were control (Ctrl) or DTx treated 2 d before analysis of spleen (spl) and pLN sections. (A) Immunofluorescence analysis for BP3+ stromal cells, 
CD35+ FDCs, and IgD+ follicular B cells. (B) In situ hybridization for Cxcl13 mRNA with serial sections stained for B220 and CD35 or for Cxcl13 and CD35. 
(C) Quantitative RT-PCR analysis for Cxcl13, Cr1 (CD35), Mfge8, and Tnsf13B (BAFF) mRNA in pLNs, spleen, and mLNs, normalized to Hprt mRNA. Data are 
representative of four experiments (mean ± SEM). Statistical analysis was performed with the two-tailed unpaired Student’s t test. *, P < 0.05; n.s., not 
significant. (D) Immunohistochemical analysis for CXCL13 and CD3 or B220 in serial sections of spleen and pLNs. Data in A, B, and D are representative of 
at least three experiments (at least two mice of each type per experiment). Bars: (A [left] and B [left and middle]) 200 µm; (A and D, right) 100 µm;  
(B [right] and D [left]) 50 µm.
revealed only a slight trend for reduced MFG-E8 expression 
after primary follicle FDC ablation (Fig. 2 C). This result ex-
tends previous in situ hybridization data indicating that MFG-
E8 is produced broadly by follicular stromal cells (Kranich 
et al., 2008) and indicates that FDCs may be unique in their 
ability to capture and display MFG-E8 protein rather than in 
its expression.
Radiation-resistant stromal cells are an important source of 
the B cell trophic factor BAFF (Gorelik et al., 2003), and FDCs 
have been suggested to contribute to this source (Allen and JEM Vol. 208, No. 12 
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2 d of FDC ablation, there was an increase in the density   
of both markers in the areas that corresponded to the B cell–
rich zones (Fig. 3 A). This increase was typically more evident 
in the spleen, where the location of the original follicles 
could be most readily discerned (Fig. 3 A). In LNs, the effect 
was more variable, with some B cell–rich areas showing   
little change in the density of these markers and others 
showing a prominent change (Fig. 3 A). Moreover, T cells 
and DCs were no longer tightly restricted to the T zone but 
were now frequently found scattered in considerable numbers 
Cyster, 2008). However, FDC ablation had no measurable 
impact on BAFF (Tnfsf13B) mRNA levels in total tissue sam-
ples (Fig. 2 C), and consistent with this observation, spleen 
and LN B cell numbers were normal in 2-d FDC-ablated 
mice (Fig. 1 D).
To  further  define  the  properties  of  the  stromal  cells 
present within follicles after FDC ablation, we examined 
the distribution of the T zone reticular marker, ER-TR7, 
and collagen type IV. In wild-type follicles, both of these 
markers were sparsely distributed (Fig. 3 A). However, within 
Figure 3.  FDC ablation leads to abnormal expression of T zone markers and less restricted positioning of T cells and DCs. Unimmunized 
CD21-DTR chimeras were control (Ctrl) or DTx treated for 2 d, and spleen and pLN sections were analyzed immunohistochemically as follows. (A) Serial 
sections were stained for T zone stromal marker ER-TR7 and collagen type IV or for naive B cells with IgD (brown). T cells and FDCs were detected with 
CD3 and CD35 (blue), respectively. (B) Sections were stained for CD3 to detect T cells (blue), CD11c to detect DCs (blue), and B220 to detect B cells 
(brown). All data are representative of at least three experiments (at least two mice per experiment). Bars: (A) 100 µm; (B) 200 µm.2502 FDCs maintain follicles and retain B cells in GCs | Wang et al.
mice that were then DTx treated, and cell migration within 
inguinal LNs was examined 2 d later by two-photon laser 
scanning microscopy. B cells continued to migrate exten-
sively within the B cell–rich regions of FDC-ablated LNs 
(Fig. 5 A and Videos 1–4), although their migration veloci-
ties were reduced (Fig. 5 B). More strikingly, the cells 
showed a notable increase in the sharpness of their turning 
angles (Fig. 5 C). The outcome of this combined reduction 
in velocity and increase in mean turning angle was an over-
all reduction in displacement over time (Fig. 5 D). Consis-
tent with the static images, T cells were frequently seen to 
penetrate deeply into the B cell–rich areas after FDC abla-
tion (Videos 1–4). The relatively modest effect of FDC ab-
lation on naive B cell migration within the B cell–rich areas 
in pLNs might reflect the continued presence of a stromal 
cell network in these zones. However, the sharper turning 
angles of the cells could indicate less effective guidance by 
this network, with cells detaching more frequently, or a 
greater amount of stromal cell–independent motility.
across the boundary into B cell areas of spleen and LNs 
(Fig. 3 B).
CCL21 mRNA, encoding a chemokine normally re-
stricted to T zone stroma, also now often extended in expres-
sion into the B cell–rich areas of spleen and LNs (Fig. 4 A). 
CCL21 protein was also distributed within B cell areas 
(Fig. 4 B). This overlap in CCL21 expression likely contrib-
utes to the diminished segregation of T cells and DCs from 
the B cell areas. In contrast, MAdCAM1 expression in the 
marginal sinus region of spleen remained intact, and CD169+ 
marginal metallophilic macrophages remained concentrated 
at the follicle boundary (not depicted).
Altered B cell migration behavior
Previous work has suggested an important role for stromal 
cells as guides for migrating lymphocytes (Bajénoff et al., 
2006). To test whether FDC ablation affected follicular B cell 
migration, CFSE-labeled B cells and CMTMR-labeled T cells 
were cotransferred to control and CD21-DTR chimeric 
Figure 4.  FDC ablation leads to overlap between B cell–rich areas and CCL21-expressing cells. Unimmunized CD21-DTR chimeras were control 
(Ctrl) or DTx treated for 2 d, and spleen and pLN sections analyzed. (A) In situ hybridization for Ccl21 mRNA (dark blue), detected alone or in combination 
with staining for B cells (B220; brown). Red dotted lines trace the interface between B cell– and T cell–rich areas, determined based on the adjacent sec-
tion. (B) Immunohistochemical analysis of CCL21 and B220 in spleen and pLN. Data are representative of at least three mice of each type analyzed in two 
independent experiments. Bars: (A) 200 µm; (B) 100 µm.JEM Vol. 208, No. 12 
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containing well developed CD35hi FDC networks in con-
trol mice and a near complete ablation of the GC FDC net-
works and GL7+ cell clusters in the treated mice (Fig. 6 B and 
not depicted). An exception was the continued presence of 
some small FDC-deficient (CD35) GL7+ B cell clusters in 
mLNs and occasionally in pLNs (Fig. 6 B). The complete-
ness of GC FDC ablation was further confirmed by the loss 
of FDC-M1+ and FcRIIb+ staining cells (Fig. 6 C). Occa-
sionally, however, there were a few residual FDCs persisting 
in the treated mice, and these would remain associated with 
small GL7+ B cell clusters (not depicted). There was also a 
FDC ablation causes acute GC loss
To test the dependence of GCs on FDCs, CD21-DTR chi-
meric mice were immunized with sheep RBCs (SRBCs) 
and then treated with DTx at days 6–8, when GCs had 
formed, and analyzed 2 d later. Flow cytometric analysis 
revealed a marked (six- to sevenfold) loss of IgDloFashiGL7hi 
GC B cells from responding pLNs and spleen (Fig. 6 A). 
The magnitude of the endogenous GC B cell response oc-
curring within the mLNs was similarly affected (Fig. 6 A). 
Immunohistochemical staining of sections from spleen and 
LNs showed a very similar picture, with large GL7+ GCs 
Figure 5.  Altered B cell motility in FDC-ablated pLNs. Two-photon laser-scanning microscopy of explanted pLNs from CD21-DTR chimeras that 
were injected with CFSE-labeled B cells and CMTMR-labeled T cells 5 d before imaging and control (Ctrl) or DTx treated 2 d before imaging. (A) 114-µm 
maximum intensity z-projection view from a video of control- and DTx-treated LNs, showing the location of CFSE-labeled B cells at a single time point 
together with measured trajectories of 50 B cells. This image corresponds to Videos 1 and 3. Bar, 100 µm. (B and C, left) Instantaneous velocities (B) and 
turning angles (C) of B cells in pLNs. Central dot plots show medians for each cell track from one representative experiment. Right bar graphs show the 
mean of the medians from three independent experiments, bars represent means, and circles represent individual experiments. (D) Mean of displacement 
squared <R2> over time. Symbols represent means, and error bars represent SEM. Data are representative of three experiments with at least 50 tracks in 
each. Statistical analysis was performed with the two-tailed unpaired Student’s t test.2504 FDCs maintain follicles and retain B cells in GCs | Wang et al.
making it unlikely that there had been an undetected surge 
in circulating corticosteroid levels (Fig. 6 E). These findings 
suggested that GC cells were dying rapidly after FDC abla-
tion because of loss of local trophic support, although they 
did not exclude the possibility that the cells were traveling 
to other sites.
loss of CXCR5hiPD1+GL7+ GC-associated Tfh cells in the 
FDC-ablated mice (Fig. 6 D). Previous work has shown   
that GC B cells and double-positive (DP) thymocytes are 
sensitive to death induced by corticosteroids (Sentman et al.,   
1991; Secord et al., 1995). There was no effect of the   
DTx plus anti-DTx treatment on DP thymocyte numbers, 
Figure 6.  FDC ablation abrogates the GC response. CD21-DTR chimeras were immunized with SRBCs, control (Ctrl) or DTx treated at day 6, and analyzed 
at day 8. (A) Dot plots and histograms show flow cytometric analysis of GC B cells (IgDlowFas+GL7+) in pLNs. Numbers show frequency of cells in indicated 
gate. Bar graphs show a summary of the data for IgDlowFas+GL7+ GC B cell numbers in pLNs, spleen, and mLNs, in which bars represent means and dots repre-
sent individual mice. (B and C) Sections of pLNs, spleen, and mLNs stained to detect follicular B cells (IgD; brown) and GC B cells (GL7; blue; B) or GC FDCs 
(FDC-M1, left; and FcRIIb, right; blue; C). Data are representative of at least three experiments (three mice per experiment). Bars: (B) 400 µm; (C) 200 µm.  
(D) Flow cytometric analysis of CD4+CXCR5hiPD1hiGL7hi follicular helper T cells in pLNs. Bar graphs show cell numbers (bars represent means, and dots represent 
individual mice). (E) Frequency and number of CD4 and CD8 DP thymocytes in control- and DTx-treated mice at day 2 after treatment. In A, D, and E, statisti-
cal analysis was performed with the two-tailed unpaired Student’s t test. Numbers below p-values in A and D indicate fold change. n.s., not significant.JEM Vol. 208, No. 12 
Article
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Figure 7.  Splenic and pLN Bcl2 transgenic GC B cells are dispersed in the absence of FDCs. ROSADTR+CD21Cre+ mice that had been reconstituted 
with Bcl2 transgenic BM were immunized with SRBCs and then control (Ctrl) or DTx treated at day 6 and analyzed at day 8. (A) Flow cytometric analysis 
of GC B cells (IgDlowFas+GL7+) in pLNs. Bar graphs show total cell numbers for pLNs, spleen (spl), and mLNs (bars indicate means, and dots represent indi-
vidual mice). Statistical analysis was performed with the two-tailed unpaired Student’s t test. n.s., not significant. (B) Sections of pLNs, spleen, and mLNs 
stained to detect GL7 (blue) and IgD (brown). Two examples of each type are shown at different magnifications. Data are representative of at least four 
experiments (more than six mice of each type). Bars: (white) 400 µm; (black) 100 µm.
FDCs are required for GC B cell clustering
In an effort to test whether rescuing GC B cell survival might 
allow GC clusters to persist in the absence of FDCs, CD21-DTR 
chimeric mice were generated using BM from B cell–specific 
Bcl2 transgenic mice (Strasser et al., 1990). The chimeras were 
then immunized to induce GC responses, treated with DTx, 
and analyzed 2 d later. Bcl2 overexpression fully rescued the GC 
B cell number that was detectable by flow cytometry in pLNs, 2506 FDCs maintain follicles and retain B cells in GCs | Wang et al.
confinement of GC B cells within GCs (Green et al., 
2011). S1PR2 was suggested to promote cell cluster-
ing in response to a gradient of S1P that is at its low-
est concentration within the center of the follicle, 
and consistent with the existence of this gradient, 
S1PR2 overexpression promotes B cell positioning 
at the follicle center (Green et al., 2011). Extracellu-
lar S1P has a half-life of only minutes (Skoura and 
Hla,  2009)  and  can  be  degraded  by  several  cell 
membrane–associated enzymes (Spiegel and Milstien, 
2003). B cells abundantly express these S1P degrad-
ing enzymes, and they efficiently degrade S1P (Green 
et al., 2011). To explore the possibility that S1P abun-
dance was kept low in the follicle center because 
of  FDC-mediated  degradation,  we  transferred 
S1PR2-overexpressing B cells into FDC-ablated mice. 
S1pr2- but not vector-transduced cells continued to 
show a preference for positioning near the center of 
the B cell areas despite the absence of FDCs (Fig. 8 A). 
Perhaps as a consequence of the thinner and less 
organized nature of the FDC-ablated B cell areas, the 
clustered S1pr2-transduced cells were sometimes 
nearer the T zone than in wild-type controls (Fig. 8 A). 
We interpret these data as indicating that FDCs 
are  not  needed  to  maintain  an  S1P  gradient,  al-
though by organizing B cells in follicles, they help 
shape the gradient. The evidence for the continued 
existence of an S1P gradient in the absence of FDCs led   
us to test the idea that FDCs and S1PR2 had redundant roles 
in clustering GC B cells in mLNs. S1PR2 deficiency has pre-
viously been shown to augment GC B cell survival because 
of reduced negative regulation of AKT (Green et al., 2011), 
leading us to consider the possibility that S1PR2-deficient 
GC B cells might survive after FDC ablation. Indeed, when 
CD21-DTR mice were generated that lacked hematopoi-
etic S1PR2, DTx treatment no longer caused a loss of mLN 
GC  B  cells  (Fig.  8  B).  However,  analysis  of  mLN  tissue   
sections from these mice showed that the GL7+ GC areas 
had been disrupted and the GC B cells had become dis-
persed (Fig. 8 C). These findings suggest that FDCs and the   
Figure 8.  FDCs and S1PR2 cooperate to promote GC  
B cell clustering. (A) Distribution of B cells transduced with 
control (hCD4-vector) or S1PR2 encoding (S1pr2-hCD4) retro-
viral constructs 1 d after transfer to control (Ctrl)- or DTx-
treated CD21-DTR chimera recipients. Splenic sections were 
stained to detect the transferred B cells (hCD4; brown) and 
endogenous B cells (B220; blue). Data are representative  
of three mice of each type analyzed in two experiments.  
(B and C) GC B cell location in mLNs of ROSADTR+CD21Cre+ mice 
reconstituted with S1pr2/ BM, immunized 8 d before with 
SRBC and control or DTx treated 2 d before analysis. (B) Flow 
cytometric analysis and numbers of GC B cells (IgDlowFas+GL7+) 
in mLNs. Statistical analysis was performed with the two-
tailed unpaired Student’s t test. n.s., not significant. (C) Sec-
tions of mLN stained for GL7 (blue) and IgD (brown). Bars:  
(A) 200 µm; (C, left) 400 µm; (C, right) 100 µm.
spleen, and mLNs of FDC-ablated mice (Fig. 7 A). Importantly, 
however, the rescued pLN and splenic GC B cells frequently 
failed to remain clustered in GCs and instead became dispersed 
within the B cell area and adjacent regions (Fig. 7 B). In mLNs, 
in contrast, GCs often persisted, although they sometimes ap-
peared smaller and less organized (Fig. 7 B). These observations 
indicate that GC FDCs contribute to the clustering of GC   
B cells in spleen and pLNs but suggested that their role in this 
process may be redundant in mLNs.
S1PR2 cooperates with FDCs to mediate GC cell clustering
Recent work has established that the migration inhibitory 
sphingosine-1-phosphate (S1P) receptor, S1PR2, promotes JEM Vol. 208, No. 12 
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Our findings of reduced total tissue CXCL13 transcript 
abundance in the spleen and mLNs after FDC ablation ex-
tends  previous  evidence  that  primary  follicle  FDCs  are  a 
source of this chemokine (Cyster et al., 2000; Allen and 
Cyster, 2008; Suzuki et al., 2010). The basis for the lack of 
effect of FDC ablation on CXCL13 transcript abundance in 
pLNs is not clear but might reflect a lesser contribution of 
FDCs to CXCL13 production in this tissue (Suzuki et al., 
2010) or altered feedback controls leading to increased ex-
pression by non-FDC stromal cells.
The major source of BAFF for maintaining follicular   
B cell numbers was identified as a radiation-resistant, pre-
sumably stromal, cell type (Gorelik et al., 2003). Our finding 
that FDC ablation did not affect BAFF transcript abundance 
in unimmunized tissue adds to the previous finding of normal 
or elevated BAFF expression in LTR-Fc–treated mice 
(Browning et al., 2005) and the presence of normal B cell 
numbers in LT- and LTR-deficient mice (Alimzhanov et al., 
1997; Koni et al., 1997). It remains to be determined what 
radiation-resistant cell types are the predominant source of 
BAFF for naive B cells, although marginal reticular cells are 
candidates (Katakai et al., 2008). Our attempts to determine 
BAFF distribution in follicles using a commercial goat anti-
BAFF reagent were unsuccessful as we observed similar staining 
patterns in lymphoid tissues from wild-type and BAFF-deficient 
(Gorelik et al., 2003) mice (not depicted). Therefore, we 
currently cannot exclude the possibility that BAFF is normally 
made by primary follicle FDCs and that there is compensatory 
up-regulation by other stromal cells after FDC ablation. As 
well as supporting naive B cell survival, BAFF has a role in 
maintenance of the GC response (Rahman et al., 2003; Vora 
et al., 2003). Our experiments have not addressed the contribu-
tion of FDCs to BAFF production in GCs.
GC FDCs have been suggested to be a source of B cell 
trophic factors (Victoratos et al., 2006; Allen and Cyster, 2008; 
Wu et al., 2009; Garin et al., 2010). Our data provide in vivo 
support for this function, although we do not exclude the 
possibility that the reduced viability of GC B cells after FDC 
ablation is secondary to the role of FDCs in keeping the cells 
clustered and thus in proximity to the antigen depot and fol-
licular helper T cells. The expression of DTR in brain and 
kidney of CD21-DTR chimeric mice also means we cannot 
fully exclude the possibility that there were changes in other 
factors that adversely affected GC B cell survival. In addition 
to possibly being a source of BAFF, GC FDCs have been 
suggested to produce IL-6 (Wu et al., 2009), sonic hedgehog, 
and hepatocyte growth factor (Allen and Cyster, 2008), addi-
tional factors which might augment cell survival. Integrin-
mediated  adhesion  to  FDCs  has  also  been  suggested  to 
contribute to GC B cell survival (Victoratos et al., 2006; 
Allen and Cyster, 2008; Garin et al., 2010). However, the 
impact of selective integrin ligand deficiency on FDCs in 
vivo has not yet been determined. The ability of S1PR2 de-
ficiency to rescue mLN GC B cells from elimination after 
FDC ablation suggests that one trophic function of FDCs is 
to promote GC B cell clustering in the S1P-low area of the 
S1P–S1PR2 pathway work in an overlapping fashion to pro-
mote GC cell clustering. The data also support the conclusion 
that S1P concentrations in the B cell–rich areas most distant 
from vascular sinuses are kept S1P low by the degrading ac-
tions of B cells rather than FDCs. By causing larger and purer 
B cell clusters to form (i.e., follicles), FDCs likely help shape 
the S1P gradient, perhaps ensuring good alignment of the S1P 
low area with the region occupied by the FDCs.
DISCUSSION
We establish that FDCs help maintain primary follicle iden-
tity; in their absence, B cell areas rapidly lose homogeneity 
and overlap with areas containing T zone stromal cells as well 
as becoming infiltrated by DCs and T cells. An important as-
pect of follicle identity imparted by FDCs may be the estab-
lishment of a zone (the follicle) that limits access of phagocytes, 
cells which might otherwise cause rapid antigen clearance, 
helping make the follicle an antigen sanctuary that supports 
long-term antigen display (Cyster, 2010). Primary follicle 
FDCs also promote naive B cell migration, increasing the 
volume the cells survey for antigen in a given period of time. 
After GC formation, we show that FDCs promote the clus-
tered state of GC B cells. The rapid death of many GC B cells 
after FDC ablation adds to other evidence suggesting that 
FDCs are needed, directly or indirectly, for maintenance of 
GC B cell viability.
Our detection of increased overlap between B cell–rich 
zones and ER-TR7, collagen type IV, and CCL21 expres-
sion in unimmunized spleen and LNs 2 d after FDC ablation 
might be explained in either of two ways. In the absence of 
FDCs, B cells may redistribute such that they become preva-
lent in areas that were previously T cell rich, such as inter-
follicular regions in LNs. Alternatively, FDCs may normally act, 
whether directly or indirectly (e.g., via B cells), to suppress 
T zone stromal features within B zones. Our current experi-
ments do not allow us to fully distinguish between these pos-
sibilities, but we suspect that both processes are occurring.   
In spleen, the preponderance of B cells over T cells made an 
assessment of the FDC-lacking follicle-equivalent areas more 
compelling than was possible in LNs, and here there were 
clear instances of CCL21 expression extending into the B cell 
zones. The ER-TR7 and collagen type IV signals also ap-
peared increased compared with the B cell areas of matched 
controls. During lymphoid tissue development, nascent B cell 
areas are occupied by ER-TR7+ stromal cells and contain 
numerous collagen type IV–positive conduits; after B cells 
arrive, some stromal cells take on FDC features, and the   
T zone stromal network and collagen type IV fibers recede 
(Bajénoff and Germain, 2009). We suggest that the exclusion 
of T zone stromal cells from follicles may be promoted in part 
by FDCs. Because the follicular and T zone stromal cell net-
works are interconnected (McNagny et al., 1991; Yoshida 
et al., 1993; Ngo et al., 1999; Bajénoff and Germain, 2009), 
this suppressive cross talk may occur by direct intercellular 
communication. Alternatively, it might occur via FDC- 
induced modifications in the B cells.2508 FDCs maintain follicles and retain B cells in GCs | Wang et al.
Animals were housed in a specific pathogen–free environment in the Labora-
tory Animal Research Center at the University of California, San Francisco 
(UCSF), and all experiments conformed to ethical principles and guidelines 
approved by the UCSF Institutional Animal Care and Use Committee.
DTx treatment. For FDC ablation, mice were injected with DTx (in 10 mM 
Tris-HCI, pH 7.5, and 1 mM of EDTA buffer; EMD) either i.p. alone or 
with a split i.p. and at six s.c. doses across the flanks, to achieve a total of 
1 ng/g body weight. In all experiments, except where stated for the initial 
experiments summarized in Fig. 1, mice were further treated 2.5–3 h later 
with an i.v. injection of DTx-specific goat polyclonal antibody (80 µg/mouse 
in PBS; Thermo Fisher Scientific).
Flow cytometry. Spleen and LN cells were isolated and stained as de-
scribed previously (Pereira et al., 2009). For GC B cell staining, cells were 
stained with PE-conjugated anti-IgD (11-26c.2a; BD), PE-Cy7–conjugated 
anti-Fas (Jo2; BD), FITC-conjugated GL7 anti–T&B cell activation antigen 
or Ly-77 (BD), and PE-Cy5.5–conjugated anti-B220 (RA3-6B2; BD). For 
Tfh staining, cells were first stained with purified anti-CXCR5 (2G8; BD), 
then with biotin-conjugated anti–rat (Invitrogen), and lastly with streptavidin–
Alexa Fluor 647, PE-conjugated anti-CD4 (RM4-5; BD), PE-Cy7–conjugated 
anti–PD-1 (RMP1-30; BioLegend), and FITC-GL7.
Immunohistochemistry, immunofluorescence, and in situ hybrid-
ization. Cryosections of 7 µm were fixed and stained immunohistochemi-
cally as previously described (Pereira et al., 2009) with the following first 
antibodies: PE-conjugated anti-IgD (11-26c.2a; BD), biotin-conjugated anti-
CD35 (8C12; BD), rat anti–mouse fibroblast (ER-TR7; Novus Biologicals), 
rabbit anti–mouse Collagen IV (Abcam), rat anti–mouse B220 (RA-6B2; 
BD), biotin-conjugated anti–T/B cell activation antigen or Ly77 (GL7; 
BD), biotin conjugated anti–mouse CD3e (145-2C11; BD), goat anti–mouse 
CXCL13 (R&D Systems), goat anti–mouse CCL21 (R&D Systems), rat 
anti-CD169 (Ser4; P. Crocker, University of Glasgow, Glasgow, Scotland, 
UK), rat anti–mouse madcam-1 (MECA-367; BD), rat anti–mouse FDC 
(FDC-M1; BD), and FITC-conjugated rat anti–mouse CD16/32 (FcRII/III; 
UCSF Hybridoma Core). For immunofluorescence, Alexa Fluor 647– 
conjugated anti-BP3, PE-conjugated anti-IgD, and FITC-conjugated anti-
CD35 were used. In situ hybridization was performed as described previously 
(Ngo et al., 1999). In brief, sections were fixed in 4% paraformaldehyde, 
prehybridized for 3 h, and hybridized overnight at 58°C with digoxigenin-
labeled probes. After washing at high stringency, sections were incubated 
with alkaline phosphatase–conjugated anti-digoxigenin antibody (Roche) 
and developed with NBT/BCIP (Roche). Images were all acquired with 
Axiovision version 4.8 using an Axio Observer Z1 microscope (Carl Zeiss).
Two-photon imaging. Explanted LNs were prepared for imaging as de-
scribed previously (Suzuki et al., 2009; Green et al., 2011). Images were ac-
quired with ZEN2009 (Carl Zeiss) using a 7MP two-photon microscope 
(Carl Zeiss) equipped with a Chameleon laser (Coherent). Each xy plane spans 
616 µm × 616 µm at a resolution of 1.19 µm per pixel, and images of 39 xy 
planes with 3-µm z spacing (total depth of 114 µm) were formed every 30 s. 
Excitation wavelength was 870 nm. Emission filters were 440–480 nm for 
second harmonic, 500–550 nm for CFSE, and 570–640 nm for CMTMR. 
Videos were made and analyzed with Imaris 5.7.2 ×64 (Bitplane), and auto-
mated tracks were generated using a 6-µm spot size. Tracks were sorted based 
on duration, from longest to shortest, and the tracks were manually verified. 
Data from cells that could be tracked for at least 20 min were used for analysis 
(50 from each experiment). The velocities, turning angles, and displacement 
of cells between each imaging frame were calculated with MATLAB (The 
MathWorks, Inc.). Annotation and final compilation of videos were performed 
with After Effects 7.0 software (Adobe). Video files were converted to MPEG 
format with AVI-MPEG Converter for Windows 1.5 (FlyDragon Software).
Retroviral transduction and cell transfer. Retroviral transductions with 
control (truncated NGFR) or S1pr2 retroviral constructs that also contained 
an IRES-truncated hCD4 reporter were performed with antigen and 
follicle,  minimizing  S1PR2-mediated  suppression  of  Akt 
prosurvival signaling (Green et al., 2011).
The mechanisms promoting GC B cell clustering to the 
follicle center and around the FDC network are beginning to 
be discerned (Cyster, 2010). CXCL13 is needed for B cells to 
accumulate in follicles and for GCs to form in their normal 
location (Ansel et al., 2000; Voigt et al., 2000; Allen et al., 
2004).  However,  there  is  at  this  time  no  evidence  that 
CXCL13 is more concentrated at the follicle center or within 
the GC than in other regions of the follicle, and CXCR5/
CXCL13-deficient mice retain the ability to form GCs 
(Förster et al., 1996; Ansel et al., 2000). The similar disrup-
tion of primary follicle organization in CXCR5- and CXCL13-
deficient mice and FDC-ablated mice might in part reflect 
the dependence of primary follicle FDCs on CXCL13-
CXCR5–mediated induction of LT12 in B cells (Förster 
et al., 1996; Ansel et al., 2000). EBI2 guides activated B cells 
to inter and outer follicular regions and down-regulation of 
EBI2 may be a necessary step in B cell movement to the fol-
licle center. However, EBI2 deficiency does not prevent the 
normal formation of GCs (Pereira et al., 2009). Thus, we in-
voke the existence of an additional organizer made by GC 
FDCs that promotes clustering of GC B cells and follicular 
helper T cells.
Previous studies found that GC formation in mLNs was 
less lymphotoxin dependent than in other lymphoid tissues 
(Koni et al., 1997; Koni and Flavell, 1999), and our experi-
ments extend these findings by showing that GC B cell clus-
tering in mLNs is less FDC dependent than at other sites. 
However, FDCs do contribute to clustering in mLNs because 
combined removal of S1PR2 and FDCs caused dispersal of 
these cells. The basis for this different property of mLN GCs 
remains to be elucidated but may relate to distinct features of 
the mLN follicular stroma, to the presence of more robust 
S1P gradients in mLN follicles, and/or to influences of the 
chronic exposure to innate stimuli from the small intestine.
By demonstrating the critical role of FDCs in maintaining 
primary follicle identity and GC cell clustering, these results 
highlight the significance of FDC appearance at sites of chronic 
B cell accumulation such as in the inflamed synovium of 
rheumatoid arthritis patients. Our results suggest that thera-
peutic agents that selectively target FDC viability may po-
tently disrupt GC B cell responses.
MATERIALS AND METHODS
Mice. C57BL/6J (B6), B6-Gt(ROSA)26Sortm1(HBEGF)Awai (Rosa-
DTR),  B6.Cg-Tg(BCL2)22Wehi/J  (Eµ-Bcl2-22),  and  B6  CD45.1  mice 
were obtained from the Jackson Laboratory. B6.Tg(Cr2-Cre)3Cgn (CD21-
Cre) mice were provided by K. Rajewsky (Immune Disease Institute, Bos-
ton, MA). To make BM chimera mice, lethally irradiated CD21-Cre × 
Rosa-DTR (CD21-DTR) mice were reconstituted for at least 6 wk with 
wild-type CD45.1, Bcl2 transgenic, or S1pr2/ (Kono et al., 2004) BM as 
described previously (Pereira et al., 2009). For induction of spleen and pLN 
GCs, mice were immunized i.p. with 2 × 108 SRBCs (Colorado Serum 
Company) as described previously (Pereira et al., 2009) or s.c. at six sites 
across flanks. For imaging experiments, 107 CFSE-labeled B cells and 107 
CMTMR-labeled T cells purified from B6 mice were injected i.v. into 
CD21-DTR chimeras to achieve a labeled cell frequency of 2–3% in LNs. JEM Vol. 208, No. 12 
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